Global Intravenous Iron Drugs Market Size, Share, Growth, Global Trends, Industry Analysis and Forecast to 2027

Price: 3600/- USD | Published Date: August 1, 2021 |

The global intravenous iron drugs market size is projected to grow at a sustainable CAGR of over 8% during the forecast period 2021 to 2027. The increasing incidence of chronic renal disorder around the world is a primary factor to drive the market growth. Furthermore, the growing geriatric population, the increasing number of diabetic patients in the global population, and the increasing number of dialysis procedures are expected to fuel the market. The increasing cases of iron deficiency coupled with the government initiative and increasing investment in the healthcare sector are projected to boost the market. Moreover, the increasing need to prevent anemia in pregnant women along with improving maternal and birth outcomes and increasing awareness of healthcare and personal care is expected to propel the market.

Market Segment Insights:

The global intravenous iron drugs market is bifurcated into product, application, and geography. On the basis of product, the market is further segmented into iron dextran, iron sucrose, ferric carboxymaltose, and others. The ferric carboxymaltose sub-segment dominated the global market in 2020 and accounted to hold the largest revenue share around half of the market. The segment is also projected to maintain its dominance over the forecast period. The increasing application of ferric carboxymaltose coupled with its superior performance and reduced cost is a major factor that contributed the segment growth.

On the basis of application, the market is sub-segmented into chronic kidney disease, inflammatory bowel disease, cancer, and others. The chronic kidney diseases segment dominated the global intravenous iron drugs market in 2020 and accounted to hold a major market share of around one-third percent of the market. The increasing incidence of chronic kidney disease coupled with the high prevalence of iron deficiency of anima in CKD patients is a major factor driving the segment growth. On the other hand, the cancer segment is expected to grow at a fast growth rate over the forecast period.

Intravenous Iron Drugs Market Forecast

To know more about the study, request sample papers

The intravenous iron drugs comprehensive study offers an in-depth analysis of industry trends, market size, competitive analysis, and market forecast – 2021 to 2027. Research Corridor report provides detailed premium insight into the global market and reveals the potential revenue streams, commercial prospects, market drivers, challenges, opportunities, issues, and events affecting the industry. In addition, the report has a dedicated section covering market forecasts and analysis for leading geographies, profiles of major companies operating in the market and expert opinion obtained from interviews with industry executives and experts from prominent companies.

The intravenous iron drugs market research report presents the analysis of each segment from 2018 to 2027 considering 2020 as the base year for the research. The compounded annual growth rate (CAGR) for each respective segment is calculated for the forecast period from 2021 to 2027.

Historical & Forecast Period

  • 2018-19 – Historical Year
  • 2020 – Base Year
  • 2021-2027 – Forecast Period

Global Intravenous Iron Drugs Market Segmentation:

By Product:

  • Iron Dextran
  • Iron Sucrose
  • Ferric Carboxymaltose
  • Others

By Application:

  • Chronic Kidney Disease
  • Inflammatory Bowel Disease
  • Cancer
  • Others

By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Geographic Coverage:

Geographically, the intravenous iron drugs market report comprises dedicated sections centering on the regional market revenue and trends. The intravenous iron drugs market has been segmented on the basis of geographic regions into North America, Europe, Asia Pacific, and Rest of the World (RoW). The RoW segment consists of Latin America and the Middle East & Africa. The intravenous iron drugs market has been extensively analyzed on the basis of various regional factors such as demographics, gross domestic product (GDP), inflation rate, acceptance, and others. Intravenous iron drugs market estimates have also been provided for the historical years 2018 & 2019 along with forecasts for the period from 2021 – 2027.

Market Competition Assessment:

Some of the major players operating in the global intravenous iron drugs market are Daiichi Sankyo Company, Ltd., Vifor Pharma Management Ltd., Sanofi S.A., AMAG Pharmaceuticals, and Actavis, Inc. Companies are exploring markets by expansion, new investment, the introduction of new services, and collaboration as their preferred strategies. Players are exploring new geography through expansion and acquisition to gain a competitive advantage through joint synergy.

List of Key Companies:

  • Daiichi Sankyo Company, Ltd.
  • Vifor Pharma Management Ltd.
  • Sanofi S.A.
  • AMAG Pharmaceuticals
  • Actavis, Inc.
  • Pharmacosmos A/S
  • Galenica Ltd.
  • Shield Therapeutics Plc
  • AbbVie Inc.
  • American Regent, Inc.

Key Questions Answered by Intravenous Iron Drugs Market Report

  • Global intravenous iron drugs market forecasts from 2021-2027
  • Regional intravenous iron drugs market forecasts from 2021-2027 covering Asia-Pacific, North America, Europe, Middle East & Africa, and Latin America
  • Country-level forecasts from 2021-2027 covering 15 major countries from the aforementioned regions
  • Intravenous iron drugs submarket forecasts from 2021-2027 covering the market by product, by application, and geography
  • Various industry models such as SWOT analysis, Value Chain Analysis pertaining to the intravenous iron drugs market
  • Analysis of the key factors driving and restraining the growth of the global, regional and country-level intravenous iron drugs markets from 2021-2027
  • Competitive Landscape and market positioning of top 10 players operating in the intravenous iron drugs market
Table of Content:

1. Preface


1.1. Report Description
1.1.1. Purpose of the Report
1.1.2. Target Audience
1.1.3. USP and Key Offerings
1.2. Research Scope
1.3. Research Methodology
1.3.1. Phase I – Secondary Research
1.3.2. Phase II – Primary Research
1.3.3. Phase III – Expert Panel Review
1.4. Assumptions

 

2. Executive Summary


2.1. Global Intravenous Iron Drugs Market Portraiture
2.2. Global Intravenous Iron Drugs Market, by Product, 2020 (USD Mn)
2.3. Global Intravenous Iron Drugs Market, by Application, 2020 (USD Mn)
2.4. Global Intravenous Iron Drugs Market, by Geography, 2020 (USD Mn)

 

3. Global Intravenous Iron Drugs Market Analysis


3.1. Intravenous Iron Drugs Market Overview
3.2. Market Inclination Insights
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Challenges
3.3.3. Opportunities
3.4. Attractive Investment Proposition
3.5. Competitive Analysis
3.6. COVID-19 Impact Analysis

 

4. Global Intravenous Iron Drugs Market By Product, 2018 – 2027 (USD Mn)


4.1. Overview
4.2. Iron Dextran
4.3. Iron Sucrose
4.4. Ferric Carboxymaltose
4.5. Others

 

5. Global Intravenous Iron Drugs Market By Application, 2018 – 2027 (USD Mn)


5.1. Overview
5.2. Chronic Kidney Disease
5.3. Inflammatory Bowel Disease
5.4. Cancer
5.5. Others

 

6. North America Intravenous Iron Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


6.1.1. Overview
6.1.2. North America Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
6.1.3. North America Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
6.1.4. North America Intravenous Iron Drugs Market by Country (2018-2027 USD Mn)
6.1.4.1. U.S.
6.1.4.1.1. U.S. Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
6.1.4.1.2. U.S. Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
6.1.4.2. Canada
6.1.4.2.1. Canada Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
6.1.4.2.2. Canada Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)

 

7. Europe Intravenous Iron Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


7.1.1. Overview
7.1.2. Europe Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.3. Europe Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
7.1.4. Europe Intravenous Iron Drugs Market by Country (2018-2027 USD Mn)
7.1.4.1. Germany
7.1.4.1.1. Germany Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.4.1.2. Germany Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
7.1.4.2. U.K.
7.1.4.2.1. U.K. Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.4.2.2. U.K. Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
7.1.4.3. France
7.1.4.3.1. France Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.4.3.2. France Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
7.1.4.4. Italy
7.1.4.4.1. Italy Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.4.4.2. Italy Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
7.1.4.5. Rest of Europe
7.1.4.5.1. Rest of Europe Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
7.1.4.5.2. Rest of Europe Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)

 

8. Asia Pacific Intravenous Iron Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


8.1.1. Overview
8.1.2. Asia Pacific Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
8.1.3. Asia Pacific Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
8.1.4. Asia Pacific Intravenous Iron Drugs Market by Country (2018-2027 USD Mn)
8.1.4.1. China
8.1.4.1.1. China Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
8.1.4.1.2. China Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
8.1.4.2. Japan
8.1.4.2.1. Japan Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
8.1.4.2.2. Japan Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
8.1.4.3. Rest of Asia Pacific
8.1.4.3.1. Rest of Asia Pacific Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
8.1.4.3.2. Rest of Asia Pacific Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)

 

9. Latin America (LATAM) Intravenous Iron Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


9.1.1. Overview
9.1.2. Latin America Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
9.1.3. Latin America Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
9.1.4. Latin America Intravenous Iron Drugs Market by Country (2018-2027 USD Mn)
9.1.4.1. Brazil
9.1.4.1.1. Brazil Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
9.1.4.1.2. Brazil Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
9.1.4.2. Mexico
9.1.4.2.1. Mexico Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
9.1.4.2.2. Mexico Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
9.1.4.3. Rest of Latin America
9.1.4.3.1. Rest of Latin America Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
9.1.4.3.2. Rest of Latin America Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)

 

10. Middle East and Africa Intravenous Iron Drugs Market Analysis and Forecast, 2018 – 2027 (USD Mn)


10.1.1. Overview
10.1.2. MEA Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
10.1.3. MEA Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
10.1.4. Middle East and Africa Intravenous Iron Drugs Market, by Country (2018-2027 USD Mn)
10.1.4.1. GCC
10.1.4.1.1. GCC Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
10.1.4.1.2. GCC Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
10.1.4.2. South Africa
10.1.4.2.1. South Africa Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
10.1.4.2.2. South Africa Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)
10.1.4.3. Rest of MEA
10.1.4.3.1. Rest of MEA Intravenous Iron Drugs Market by Product (2018-2027 USD Mn)
10.1.4.3.2. Rest of MEA Intravenous Iron Drugs Market by Application (2018-2027 USD Mn)

 

11. Company Profiles


11.1. Daiichi Sankyo Company, Ltd.
11.1.1. Business Description
11.1.2. Financial Health and Budget Allocation
11.1.3. Product Positions/Portfolio
11.1.4. Recent Development
11.1.5. SWOT Analysis
11.2. Vifor Pharma Management Ltd.
11.2.1. Business Description
11.2.2. Financial Health and Budget Allocation
11.2.3. Product Positions/Portfolio
11.2.4. Recent Development
11.2.5. SWOT Analysis
11.3. Sanofi S.A.
11.3.1. Business Description
11.3.2. Financial Health and Budget Allocation
11.3.3. Product Positions/Portfolio
11.3.4. Recent Development
11.3.5. SWOT Analysis
11.4. AMAG Pharmaceuticals
11.4.1. Business Description
11.4.2. Financial Health and Budget Allocation
11.4.3. Product Positions/Portfolio
11.4.4. Recent Development
11.4.5. SWOT Analysis
11.5. Actavis, Inc.
11.5.1. Business Description
11.5.2. Financial Health and Budget Allocation
11.5.3. Product Positions/Portfolio
11.5.4. Recent Development
11.5.5. SWOT Analysis
11.6. Pharmacosmos A/S
11.6.1. Business Description
11.6.2. Financial Health and Budget Allocation
11.6.3. Product Positions/Portfolio
11.6.4. Recent Development
11.6.5. SWOT Analysis
11.7. Galenica Ltd.
11.7.1. Business Description
11.7.2. Financial Health and Budget Allocation
11.7.3. Product Positions/Portfolio
11.7.4. Recent Development
11.7.5. SWOT Analysis
11.8. Shield Therapeutics Plc
11.8.1. Business Description
11.8.2. Financial Health and Budget Allocation
11.8.3. Product Positions/Portfolio
11.8.4. Recent Development
11.8.5. SWOT Analysis
11.9. AbbVie Inc.
11.9.1. Business Description
11.9.2. Financial Health and Budget Allocation
11.9.3. Product Positions/Portfolio
11.9.4. Recent Development
11.9.5. SWOT Analysis
11.10. American Regent, Inc.
11.10.1. Business Description
11.10.2. Financial Health and Budget Allocation
11.10.3. Product Positions/Portfolio
11.10.4. Recent Development
11.10.5. SWOT Analysis
Fill the given form to inquiry before buying for Intravenous Iron Drugs Market Report

Your Designtaion (required):


(Additional country analysis and conmapny analysis will be added according to the request, please read our FAQs below)
(Reports covers the COVID-19 impacts on the market)

Request Report Sample
Inquiry Before Buying



Frequently Asked Questions (FAQs):
A. Yes, we provide customization with every report to fulfill your market research requirement.
A. No, generally we don’t charge for report customization.
A. Yes, we will add the more coutries analysis in the report, please mention the countries you are looking.
A. Yes, we provide research support for all our clients to resolve their issue regarding the report.
A. Yes, you can purchase only a regional or a country market report with our best price which is less than the global report.
A. Yes, we provide a better discount for startups and individuals.
A. Our database consists of over 70,000 market research reports; if still not available on the website, feel free to write us. Our team will be happy to assist you in the same. Let us know if you are looking for the dataset.
(For more information, feel free to write us at sales@researchcorridor.com)
Select License Type
$3600/- Single User License
$4800/- Multi User License
$6400/- Corporate License

Paypal Certified Payment
Why To Choose Us:
  • Markets in over 150 countries analyzed granularly
  • 35% of our total client are returning clients
  • 100,000+ data points in our comprehensive database
  • 24x5 availability - we are always there when you need us
  • Our expert team will assist you with all research need and customization
  • Our expert research analysts will resolve your every query before and after purchasing the report
  • We focus on the accuracy and quality of the report
  • Our analyst will provide deep insights into the report

Impacts of COVID-19
COVID-19 Impact on the Intravenous Iron Drugs Market

For Any Assitance

Call Us: +1 520-686-7060
Email: sales@researchcorridor.com

Our Clients